Subscribe
fda-1
carmendorin / iStockphoto.com
3 January 2018Americas

FDA reveals further steps to encourage generic competition

The US Food and Drug Administration (FDA) revealed additional steps aimed at encouraging generic competition today.

Already registered?

Login to your account

To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.

Two Weeks Free Trial

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk


More on this story

Big Pharma
FDA to focus on data in new ‘top strategic priority’
7 December 2018   The US Food and Drug Administration has announced a new strategy for the use of “real-world evidence” and “real-world data” to improve its regulation of new drugs.
Americas
FDA issues latest guidance to stop ‘gaming’ of system
3 October 2018   Scott Gottlieb, commissioner of the Food and Drug Administration,, yesterday announced another set of guidelines aimed at facilitating the entry of generic drugs to the market and preventing “gaming” of the approval system.
Americas
FDA identifies companies ‘potentially blocking access’ to drug samples
21 May 2018   The US Food and Drug Administration has published a list of companies that it suspects might be preventing generic drug producers accessing samples of branded products.


Editor's picks

Life sciences leaders recognised at LSPN Awards USA 2025
Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025

Editor's picks

Americas
Life sciences leaders recognised at LSPN Awards USA 2025
8 May 2025
Americas
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
6 May 2025
Americas
Why US patent reform is ‘essential’ for US economic prosperity and security
29 April 2025
Europe
Meril v Edwards: Harmonisation of obviousness at the UPC and the EPO
24 April 2025
Americas
WIPR Diversity & Inclusion reveals Top 100 People in IP for 2025
24 April 2025
Big Pharma
AstraZeneca unit faces class-action suit over alleged Soliris monopoly
17 April 2025

More on this story

Big Pharma
FDA to focus on data in new ‘top strategic priority’
7 December 2018   The US Food and Drug Administration has announced a new strategy for the use of “real-world evidence” and “real-world data” to improve its regulation of new drugs.
Americas
FDA issues latest guidance to stop ‘gaming’ of system
3 October 2018   Scott Gottlieb, commissioner of the Food and Drug Administration,, yesterday announced another set of guidelines aimed at facilitating the entry of generic drugs to the market and preventing “gaming” of the approval system.
Americas
FDA identifies companies ‘potentially blocking access’ to drug samples
21 May 2018   The US Food and Drug Administration has published a list of companies that it suspects might be preventing generic drug producers accessing samples of branded products.

More on this story

Big Pharma
FDA to focus on data in new ‘top strategic priority’
7 December 2018   The US Food and Drug Administration has announced a new strategy for the use of “real-world evidence” and “real-world data” to improve its regulation of new drugs.
Americas
FDA issues latest guidance to stop ‘gaming’ of system
3 October 2018   Scott Gottlieb, commissioner of the Food and Drug Administration,, yesterday announced another set of guidelines aimed at facilitating the entry of generic drugs to the market and preventing “gaming” of the approval system.
Americas
FDA identifies companies ‘potentially blocking access’ to drug samples
21 May 2018   The US Food and Drug Administration has published a list of companies that it suspects might be preventing generic drug producers accessing samples of branded products.

More features

Life sciences leaders recognised at LSPN Awards USA 2025
UK-India trade deal is ‘a missed opportunity for UK pharma’, says industry body
LSPN: Counsel grapple with AI’s impact on training and critical thinking
'Nothing can stand in the way of our work': Ukraine resumes IP system
LSPN: Trump's policy storm causing chaos and confusion
Taylor Wessing expands in Europe with Paris team
LSPN: Using ‘the patentee’s friend’ in Section 112 claims
ResMed voids sleep apnoea tech patent at PTAB